Kaciulyte Juste, Sordi Silvia, Luridiana Gianluigi, Marcasciano Marco, Lo Torto Federico, Cavalieri Enrico, Codolini Luca, Cuomo Roberto, Rozen Warren Matthew, Seth Ishith, Ribuffo Diego, Casella Donato
Oncologic Breast Surgery Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
Unit of Plastic and Reconstructive Surgery, Department of Surgery "P. Valdoni", Policlinico Umberto I, Sapienza University of Rome, 00185 Roma, Italy.
J Clin Med. 2024 Dec 7;13(23):7459. doi: 10.3390/jcm13237459.
In alloplastic breast reconstruction, the choice of implant positioning and the selection of periprosthetic devices is a critical and challenging decision. Surgeons must navigate between various biologic and synthetic meshes, including acellular dermal matrices (ADM). This study aimed to propose a simple selection tool for periprosthetic devices in prepectoral breast reconstruction. Patients scheduled for mastectomy followed by implant-based breast reconstruction between September 2019 and December 2023 were included. Preoperative risk assessments were performed using the Pre-Bra Score, and only those deemed suitable for prepectoral implant placement were selected. Mastectomy flap thickness was used as an independent criterion, and only cases with flap thicknesses less than 1 cm were included. A total of 70 cases with an average flap thickness of 0.7 cm (range, 0.4-0.9 cm), as measured by preoperative contrast-enhanced spectral mammography (CESM), underwent prepectoral reconstruction with ADM covering the implant. Of these, 25 patients (35%) received direct-to-implant reconstruction, while 45 (65%) underwent two-stage reconstruction with a temporary tissue expander. Postoperative complications were recorded during a minimum follow-up period of 6 months. Over an average follow-up duration of 17.5 months (range 6-36 months), no major complications were observed. Minor complications occurred in seven patients: infection (1.28%), seroma (3.85%), and superficial skin necrosis (1.28%). Additionally, 21 patients (30%) experienced rippling, and secondary lipofilling was scheduled. The incidence of rippling was reduced by 40% through ADM in this patient subgroup, reducing the need for secondary aesthetic refinements.
在异体材料乳房重建中,植入物的放置位置选择和假体周围装置的选择是一个关键且具有挑战性的决定。外科医生必须在各种生物和合成网片之间做出选择,包括脱细胞真皮基质(ADM)。本研究旨在为胸前区乳房重建中的假体周围装置提出一种简单的选择工具。纳入了2019年9月至2023年12月期间计划进行乳房切除术后基于植入物的乳房重建的患者。使用术前胸罩评分进行术前风险评估,仅选择那些被认为适合胸前区植入物放置的患者。乳房切除皮瓣厚度用作独立标准,仅纳入皮瓣厚度小于1厘米的病例。通过术前对比增强光谱乳腺造影(CESM)测量,共有70例平均皮瓣厚度为0.7厘米(范围0.4 - 0.9厘米)的患者接受了用ADM覆盖植入物的胸前区重建。其中,25例患者(35%)接受了直接植入重建,而45例(65%)接受了使用临时组织扩张器的两阶段重建。在至少6个月的最短随访期内记录术后并发症。在平均随访期17.5个月(范围6 - 36个月)内,未观察到重大并发症。7例患者出现轻微并发症:感染(1.28%)、血清肿(3.85%)和浅表皮肤坏死(1.28%)。此外,21例患者(30%)出现了波纹现象,并计划进行二次脂肪填充。在该患者亚组中,通过ADM使波纹发生率降低了40%,减少了二次美学修复的需求。